Copayments for Prescription Drugs: The Drivers of Demand Responses
Health Economics · 2025
DOI: 10.1002/hec.4955 ↗At a glance
Journal article in Health Economics, 2025. Written by Jouko Verho and 1 co-authors. Institution: VATT Institute for Economic Research and Finnish Center of Excellence in Tax Systems Research (FIT), Helsinki, Finland. Major MEDLINE topics: Prescription Drugs, Deductibles and Coinsurance, Cost Sharing. 18 references. Funded by: Academy of Finland.
Abstract (original language)
We study the demand responses of the drug copayment threshold in Finland using detailed prescription drug purchase data. The analysis reveals that the average drug costs increase discontinuously by 17% at the threshold above which out‐of‐pocket drug costs decrease substantially. Our results suggest an average price elasticity of −0.17, which indicates evident moral hazard costs. Approximately 80% of the overall effect is due to individuals buying drugs in larger quantities rather than purchasing higher‐priced drugs. The heterogeneity analysis suggests that the responses are largest for drug categories taken on an as‐needed rather than a regular basis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- VATT Institute for Economic Research and Finnish Center of Excellence in Tax Systems Research (FIT), Helsinki, Finland.
- Tampere University, FIT and VATT, Helsinki, Finland.
ORCID profiles: Jouko Verho
Funding
- Academy of Finland
Cite
APA
Verho, J., & Harju, J. (2025). Copayments for Prescription Drugs: The Drivers of Demand Responses. Health Economics. https://doi.org/10.1002/hec.4955
Vancouver
Verho J, Harju J. Copayments for Prescription Drugs: The Drivers of Demand Responses. Health Economics. 2025. doi:10.1002/hec.4955
BibTeX
@article{Verho2025,
author = {Verho, Jouko and Harju, Jarkko},
title = {Copayments for Prescription Drugs: The Drivers of Demand Responses},
journal = {Health Economics},
year = {2025},
doi = {10.1002/hec.4955}
}
EUVIMED